FDA Cautions Antibody Test Developers Against Falsely Claiming Tests are Authorized

After opening the door to commercial manufacturers and laboratory developers to market serological tests to detect antibodies to the novel coronavirus (SARS-CoV-2), with minimal regulatory oversight, the US Food and Drug Administration (FDA) is cautioning against companies falsely claiming their tests are approved or authorized.